BSE Live
Oct 01, 16:00Prev. Close
35.15
Open Price
35.15
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
35.15 (214560)
NSE Live
Dec 27, 11:22Prev. Close
-
Open Price
-
Bid Price (Qty.)
- (0)
Offer Price (Qty.)
- (0)
Balance Sheet of Shukra Pharmaceuticals (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
EQUITIES AND LIABILITIES | ||||||
SHAREHOLDER'S FUNDS | ||||||
Equity Share Capital | 43.79 | 10.95 | 3.91 | 1.57 | 1.57 | |
Total Share Capital | 43.79 | 10.95 | 3.91 | 1.57 | 1.57 | |
Reserves and Surplus | 19.05 | 46.69 | 21.38 | 14.78 | 14.03 | |
Total Reserves and Surplus | 19.05 | 46.69 | 21.38 | 14.78 | 14.03 | |
Total Shareholders Funds | 62.84 | 57.64 | 25.30 | 16.35 | 15.60 | |
NON-CURRENT LIABILITIES | ||||||
Long Term Borrowings | 3.11 | 2.66 | 3.77 | 3.13 | 9.77 | |
Deferred Tax Liabilities [Net] | 3.41 | 3.27 | 3.29 | 3.26 | 3.20 | |
Other Long Term Liabilities | 0.00 | 0.00 | 0.11 | 0.00 | 0.00 | |
Long Term Provisions | 0.13 | 0.11 | 0.00 | 0.00 | 0.00 | |
Total Non-Current Liabilities | 6.65 | 6.04 | 7.16 | 6.39 | 12.97 | |
CURRENT LIABILITIES | ||||||
Short Term Borrowings | 1.06 | 0.50 | 1.31 | 0.25 | 0.00 | |
Trade Payables | 9.22 | 7.22 | 34.25 | 8.59 | 5.33 | |
Other Current Liabilities | 4.27 | 5.65 | 6.94 | 3.54 | 0.00 | |
Short Term Provisions | 2.74 | 0.79 | 0.00 | 0.00 | 0.86 | |
Total Current Liabilities | 17.28 | 14.15 | 42.51 | 12.38 | 6.19 | |
Total Capital And Liabilities | 86.77 | 77.84 | 74.97 | 35.11 | 34.76 | |
ASSETS | ||||||
NON-CURRENT ASSETS | ||||||
Tangible Assets | 19.40 | 19.94 | 20.23 | 17.58 | 17.69 | |
Intangible Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Capital Work-In-Progress | 1.95 | 1.66 | 1.66 | 1.66 | 1.66 | |
Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Fixed Assets | 21.34 | 21.60 | 21.89 | 19.24 | 19.35 | |
Non-Current Investments | 0.00 | 0.00 | 0.00 | 0.20 | 0.19 | |
Deferred Tax Assets [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Long Term Loans And Advances | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Other Non-Current Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Total Non-Current Assets | 21.34 | 21.60 | 21.89 | 19.45 | 19.55 | |
CURRENT ASSETS | ||||||
Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Inventories | 9.95 | 2.31 | 3.16 | 3.95 | 1.68 | |
Trade Receivables | 8.77 | 24.51 | 30.19 | 7.40 | 8.90 | |
Cash And Cash Equivalents | 12.12 | 9.98 | 3.97 | 0.09 | 0.50 | |
Short Term Loans And Advances | 10.23 | 1.98 | 2.28 | 3.12 | 3.98 | |
OtherCurrentAssets | 24.36 | 17.45 | 13.48 | 1.11 | 0.14 | |
Total Current Assets | 65.43 | 56.23 | 53.07 | 15.67 | 15.22 | |
Total Assets | 86.77 | 77.84 | 74.97 | 35.11 | 34.76 | |
OTHER ADDITIONAL INFORMATION | ||||||
CONTINGENT LIABILITIES, COMMITMENTS | ||||||
Contingent Liabilities | 0.00 | 1.40 | 1.40 | 0.00 | 0.00 | |
CIF VALUE OF IMPORTS | ||||||
Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Capital Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
EXPENDITURE IN FOREIGN EXCHANGE | ||||||
Expenditure In Foreign Currency | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
Dividend Remittance In Foreign Currency | -- | -- | -- | -- | -- | |
EARNINGS IN FOREIGN EXCHANGE | ||||||
FOB Value Of Goods | -- | -- | -- | -- | -- | |
Other Earnings | -- | -- | -- | -- | -- | |
BONUS DETAILS | ||||||
Bonus Equity Share Capital | -- | -- | -- | -- | -- | |
NON-CURRENT INVESTMENTS | ||||||
Non-Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
Non-Current Investments Unquoted Book Value | -- | -- | -- | 0.20 | 0.19 | |
CURRENT INVESTMENTS | ||||||
Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
Current Investments Unquoted Book Value | -- | -- | -- | -- | -- |
12.06.2025
Shukra Pharma Standalone March 2025 Net Sales at Rs 13.27 crore, up 21.92% Y-o-Y
26.11.2024
Shukra Pharma Standalone September 2024 Net Sales at Rs 5.56 crore, down 77.45% Y-o-Y
13.08.2024
Shukra Pharma Standalone June 2024 Net Sales at Rs 3.18 crore, down 84.24% Y-o-Y
07.06.2024
Shukra Pharma Standalone March 2024 Net Sales at Rs 10.88 crore, down 76.47% Y-o-Y